Clinical Trials Browser

NIH × Leukemia, Myeloid, Acute × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

NCT00012376 2013-01-09

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer

Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, Blast Crisis, Hemoglobinuria, Paroxysmal, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Clinical Trials

Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer